Joseph C. Wu, MD, PhD, FAHA
Dr. Joseph Wu is president-elect of the American Heart Association (AHA) for 2022-23. He is Director of Stanford Cardiovascular Institute and Simon H. Stertzer, MD, Professor of Medicine and Radiology at Stanford University. Dr. Wu received his MD from Yale University and PhD (Molecular & Medical Pharmacology) at UCLA. He is board certified in cardiology.
Dr. Wu’s lab works on cardiovascular genomics and induced pluripotent stem cells (iPSCs) to understand basic disease mechanisms, accelerate drug discovery and screening, develop “clinical trial in a dish” concept, and implement precision medicine for patients. Dr. Wu has published >450 manuscripts with H-index of 114 on Google scholar. He is listed as top 1% of highly cited researchers by Web of Science for past 4 years (2018, 2019, 2020, 2021).
Dr. Wu is a recipient of the National Institutes of Health (NIH) Director’s New Innovator Award, NIH Roadmap Transformative Award, Presidential Early Career Award for Scientists and Engineers (PECASE) given out by President Obama at the White House, American Heart Association (AHA) Distinguished Scientist Award, AHA Merit Award, and Burroughs Wellcome Foundation Innovation in Regulatory Science Award. Dr. Wu serves on the FDA Cellular, Tissue, and Gene Therapies Advisory Committee. He is on the Board of the Keystone Symposia.
Dr. Wu is an elected member of Association of University Cardiologists (AUC), American Institute for Medical and Biological Engineering (AIMBE), American Association for the Advancement of Science (AAAS), American Association of Physicians (AAP), and National Academy of Medicine (NAM).